"I Think It's Been Met With a Shrug:" Oncologists' Views Toward and Experiences With Right-to-Try.

ABSTRACT:

Background

The federal Right-to-Try (RTT) Act created an alternate regulatory pathway for preapproval access to investigational drugs. A few studies have examined the experiences of physicians with the Food and Drug Administration's Expanded Access Programs, but to our knowledge, no study has yet to examine their attitudes and experiences toward RTT.

Methods

This study explored the views of 21 oncologists at a major cancer center with 3 main sites across the United States using semi-structured interviews and qualitative analysis. Participants were selected to have experience with Expanded Access Programs.

Results

Most oncologists had limited familiarity with RTT, and several reported confusion about the legislation, including whether patients have a right to investiga

SUBMITTER: Smith C 

PROVIDER: S-EPMC8248965 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature